title: IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3.
abstract: IL-6 is a growth and survival factor for myeloma cells, although the mechanism by which it induces myeloma cell proliferation through gene expression is largely unknown. Microarray analysis showed that some B-cell lymphoma-associated oncogenes such as Bcl6, which is absent in normal plasma cells, were upregulated by IL-6 in IL-6-dependent myeloma cell lines. We found that Bcl6 variant 2 was upregulated by STAT3. ChIP assay and EMSA showed that STAT3 bound to the upstream region of variant 2 DNA. Expression of p53, a direct target gene of Bcl6, was downregulated in the IL-6-stimulated cells, and this process was impaired by an HDAC inhibitor. Bcl6 was knocked down by introducing small hairpin RNA, resulting in decreased proliferation and increased sensitivity to a DNA damaging agent. Thus, STAT3-inducible Bcl6 variant 2 appears to generate an important IL-6 signal that supports proliferation and survival of IL-6-dependent myeloma cells.
authors.affiliation: Department of Bio-Signal Analysis, Yamaguchi University Graduate School of Medicine, Minami Kogushi 1-1-1, Ube, Yamaguchi 755-8505, Japan. tsuyama@yamaguchi-u.ac.jp
authors.forename: Naohiro
authors.initials: N
authors.lastname: Tsuyama
authors.forename: Inaho
authors.initials: I
authors.lastname: Danjoh
authors.forename: Ken-Ichiro
authors.initials: K
authors.lastname: Otsuyama
authors.forename: Masanori
authors.initials: M
authors.lastname: Obata
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Tahara
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Ohta
authors.forename: Hideaki
authors.initials: H
authors.lastname: Ishikawa
mesh_terms: D024506:5' Flanking Region; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015850:Interleukin-6 / Q000494:pharmacology*; D009101:Multiple Myeloma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051560:Proto-Oncogene Proteins c-bcl-6; D011960:Receptors, Estrogen / Q000378:metabolism; D050796:STAT3 Transcription Factor; D015534:Trans-Activators / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: C084103:BCL6 protein, human; D004268:DNA-Binding Proteins; D015850:Interleukin-6; D051560:Proto-Oncogene Proteins c-bcl-6; D011960:Receptors, Estrogen; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D015534:Trans-Activators